Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/130353
Campo DC Valoridioma
dc.contributor.authorRecalde, Martinaen_US
dc.contributor.authorDávila Batista, Verónicaen_US
dc.contributor.authorDíaz, Yesikaen_US
dc.contributor.authorLeitzmann, Michaelen_US
dc.contributor.authorRomieu, Isabelleen_US
dc.contributor.authorFreisling, Heinzen_US
dc.contributor.authorDuarte-Salles, Talitaen_US
dc.date.accessioned2024-05-13T13:36:33Z-
dc.date.available2024-05-13T13:36:33Z-
dc.date.issued2021en_US
dc.identifier.issn1741-7015en_US
dc.identifier.urihttp://hdl.handle.net/10553/130353-
dc.description.abstractBackground: A high body mass index (BMI) has been associated with increased risk of several cancers; however, whether BMI is related to a larger number of cancers than currently recognized is unclear. Moreover, whether waist circumference (WC) is more strongly associated with specific cancers than BMI is not well established. We aimed to investigate the associations between BMI and 26 cancers accounting for non-linearity and residual confounding by smoking status as well as to compare cancer risk estimates between BMI and WC. Methods: Prospective cohort study with population-based electronic health records from Catalonia, Spain. We included 3,658,417 adults aged ≥ 18 years and free of cancer at baseline between 2006 and 2017. Our main outcome measures were cause-specific hazard ratios (HRs) with 99% confidence intervals (CIs) for incident cancer at 26 anatomical sites. Results: After a median follow-up time of 8.3 years, 202,837 participants were diagnosed with cancer. A higher BMI was positively associated with risk of nine cancers (corpus uteri, kidney, gallbladder, thyroid, colorectal, breast post-menopausal, multiple myeloma, leukemia, non-Hodgkin lymphoma) and was positively associated with three additional cancers among never smokers (head and neck, brain and central nervous system, Hodgkin lymphoma). The respective HRs (per 5 kg/m2 increment) ranged from 1.04 (99%CI 1.01 to 1.08) for non-Hodgkin lymphoma to 1.49 (1.45 to 1.53) for corpus uteri cancer. While BMI was negatively associated to five cancer types in the linear analyses of the overall population, accounting for non-linearity revealed that BMI was associated to prostate cancer in a U-shaped manner and to head and neck, esophagus, larynx, and trachea, bronchus and lung cancers in an L-shaped fashion, suggesting that low BMIs are an approximation of heavy smoking. Of the 291,305 participants with a WC measurement, 27,837 were diagnosed with cancer. The 99%CIs of the BMI and WC point estimates (per 1 standard deviation increment) overlapped for all cancers. Conclusions: In this large Southern European study, a higher BMI was associated with increased risk of twelve cancers, including four hematological and head and neck (only among never smokers) cancers. Furthermore, BMI and WC showed comparable estimates of cancer risk associated with adiposity.en_US
dc.languageengen_US
dc.relationOBECANen_US
dc.relation.ispartofBMC Medicineen_US
dc.sourceBMC Medicine [1741-7015], v. 19 (Enero 2021)en_US
dc.subject32 Ciencias médicasen_US
dc.subject3206 Ciencias de la nutriciónen_US
dc.subject320713 Oncologíaen_US
dc.subject.otherAdiposityen_US
dc.subject.otherBody fat distributionen_US
dc.subject.otherBody mass indexen_US
dc.subject.otherBody sizeen_US
dc.subject.otherCanceren_US
dc.subject.otherElectronic health recordsen_US
dc.subject.otherObesityen_US
dc.subject.otherWaist circumferenceen_US
dc.titleBody mass index and waist circumference in relation to the risk of 26 types of cancer: a prospective cohort study of 3.5 million adults in Spainen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1186/s12916-020-01877-3en_US
dc.identifier.pmid33441148-
dc.identifier.scopus2-s2.0-85099476222-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid0000-0002-8274-0357-
dc.identifier.issue1-
dc.relation.volume19en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages14en_US
dc.utils.revisionen_US
dc.date.coverdateEnero 2021en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr3,405
dc.description.jcr11,15
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
dc.description.miaricds10,8
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0001-8888-395X-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameDávila Batista, Verónica-
Colección:Artículos
Adobe PDF (1,86 MB)
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.